Tracking error of the Index fund (0.08%) is low
This is a measure of how well an Index fund/ETF has been able to replicate the performance of the benchmark its tracking. As a passive investor, lower tracking error is always better
What is Tracking Error?
Expense ratio of the Index fund (0.48%) is higher than average expense ratio of other Index funds/ETFs (0.34%) tracking NIFTY Pharma Total Return Index
This measures the relative expense of the index fund/ETF with respect to average expense ratio all index funds/ETFs tracking the same benchmark. Investors should always prefer schemes with lower expense, everything else remaining the same
What is Expense ratio?
3-year CAGR of 23.11% is between 25th and 75th percentile in its category - Equity: Sectoral-Pharma
This is measured by percentile rank of the scheme in its category based on 3-year CAGR. Lower rank implies that scheme was a relative outperformer in its category
What is CAGR (3Y)?
Tracking difference of the Index fund (0.6%) is in a reasonable range
This measures the difference in returns (last 1 year) between the Index fund/ETF and its respective benchmark. Lower absolute tracking difference is better
What is Tracking Difference (1Y)?
The Scheme seeks to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index
